Teva Pharmaceutical Industries Ltd
Close on Nov 17, 2026Market cap $49.66BP/E 71.0Yield –
Teva Pharmaceutical Industries Beneficial Interest Collected in Exchange for by Quarter
Beneficial Interest Collected in Exchange for Securitized Trade Receivables ($M)
Teva Pharmaceutical Industries Beneficial Interest Collected in Exchange for: $327M in Q3 2026, up 19.3% from a year earlier.
Where the Q3 2026 figure comes from
“|| Beneficial interest collected in exchange for securitized account receivables | 327 | 274”
Source: Form 8-K Earnings Release (0001171843-26-007054) ↗
Reported in SEC Form 10-K / Form 10-Q / Form 8-K Earnings Releases.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Teva Pharmaceutical Industries Beneficial Interest Collected in Exchange for ($M), quarterly Q1 2018–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/fcf-sec-ar
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?